Skip to content

Drug interactions

Elvitegravir / cobicistat / emtricitabine / tenofovir df + Etoposide

Severity: Major

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Etoposide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cobicistat is a potent CYP3A4 inhibitor and may increase etoposide exposure. This can worsen myelosuppression, mucositis and other cytotoxic toxicity.

What this interaction means in plain words

Elvitegravir / cobicistat / emtricitabine / tenofovir df and Etoposide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Cobicistat inhibits CYP3A4 and P-glycoprotein, reducing etoposide metabolism and clearance.

What to do

Prefer an antiretroviral regimen without a pharmacokinetic booster during etoposide therapy. If unavoidable, monitor blood counts closely and consider etoposide dose reduction.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elvitegravir / cobicistat / emtricitabine / tenofovir df and Etoposide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Etoposide?

MediHelp rates the interaction as major. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Etoposide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cobicistat is a potent CYP3A4 inhibitor and may increase etoposide exposure. This can worsen myelosuppression, mucositis and other cytotoxic toxicity.

How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Etoposide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an antiretroviral regimen without a pharmacokinetic booster during etoposide therapy. If unavoidable, monitor blood counts closely and consider etoposide dose reduction.

What other medicines interact with Etoposide?

MediHelp also lists interactions of Etoposide with, for example, Adenovirus types 4 and 7 live, Pentostatin, Cyclosporine. The full list is on the Etoposide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in